Workflow
系统装置
icon
Search documents
蓝晓科技跌2.08%,成交额1.47亿元,主力资金净流出612.10万元
Xin Lang Cai Jing· 2025-09-15 05:57
9月15日,蓝晓科技盘中下跌2.08%,截至13:30,报54.20元/股,成交1.47亿元,换手率0.87%,总市值 275.15亿元。 资金流向方面,主力资金净流出612.10万元,特大单买入242.24万元,占比1.65%,卖出536.69万元,占 比3.65%;大单买入1933.45万元,占比13.16%,卖出2251.09万元,占比15.32%。 蓝晓科技今年以来股价涨14.66%,近5个交易日跌3.73%,近20日涨3.04%,近60日涨13.36%。 资料显示,西安蓝晓科技新材料股份有限公司位于陕西省西安市高新区锦业路135号,成立日期2001年4 月5日,上市日期2015年7月2日,公司主营业务涉及研发、生产和销售吸附分离材料以及围绕吸附分离 材料核心形成的配套系统装置和吸附分离技术一体化的柔性解决方案。主营业务收入构成为:吸附材料 80.71%,系统装置14.70%,技术服务2.95%,其他1.63%。 截至6月30日,蓝晓科技股东户数1.90万,较上期减少9.84%;人均流通股16100股,较上期增加 10.92%。2025年1月-6月,蓝晓科技实现营业收入12.47亿元,同比减少3.64 ...
蓝晓科技(300487):Q2业绩环比高增,加速生科板块产能布局
Huaan Securities· 2025-08-25 09:32
Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Viewpoints - The company reported a significant increase in Q2 performance, with a quarter-on-quarter revenue growth of 16.27% and a net profit increase of 30.16% [5] - The company achieved a total revenue of 12.47 billion yuan in the first half of 2025, a year-on-year decrease of 3.64%, while the net profit attributable to the parent company rose by 10.01% to 4.45 billion yuan [4] - The company is focusing on expanding its capacity in the life sciences sector and enhancing its global presence, with significant growth in high-margin businesses such as life sciences and ultra-pure water materials [6][9] Summary by Relevant Sections Financial Performance - In Q2 2025, the company achieved a revenue of 6.71 billion yuan, a year-on-year increase of 1.06% and a quarter-on-quarter increase of 16.27% [5] - The gross profit margin for the first half of 2025 was 51.26%, an increase of 3.8 percentage points year-on-year [6] - The company expects to achieve net profits of 9.69 billion, 11.89 billion, and 14.49 billion yuan for the years 2025 to 2027, corresponding to P/E ratios of 27, 22, and 18 times respectively [10] Business Segments - The revenue from the adsorption separation materials segment reached 10.07 billion yuan, with a year-on-year growth of 3.40% [6] - The life sciences materials segment generated 3.20 billion yuan in revenue, up 12.43% year-on-year, driven by the growth of peptide solid-phase synthesis carriers [6] - The company has successfully launched the first production line of the salt lake lithium extraction project, which is expected to contribute to future revenue growth [7][8] Strategic Initiatives - The company plans to establish a high-standard industrial park in Weinan, Shaanxi, to enhance its production capacity in chromatography media and other high-value products [9] - The company has signed long-term contracts with leading semiconductor clients in the ultra-pure water segment, indicating strong demand and growth potential [9]
蓝晓科技跌2.00%,成交额2.94亿元,主力资金净流出3578.03万元
Xin Lang Zheng Quan· 2025-08-25 03:49
Core Viewpoint - Blue Sky Technology's stock has experienced fluctuations, with a recent decline of 2.00% on August 25, 2023, while the company has shown a year-to-date increase of 10.83% in stock price [1] Group 1: Financial Performance - As of June 30, 2023, Blue Sky Technology reported a revenue of 1.247 billion yuan, a year-on-year decrease of 3.64%, while the net profit attributable to shareholders was 445 million yuan, reflecting a year-on-year growth of 10.01% [2] - The company has distributed a total of 1.136 billion yuan in dividends since its A-share listing, with 866 million yuan distributed over the past three years [3] Group 2: Shareholder and Market Activity - The number of shareholders decreased by 9.84% to 19,000 as of June 30, 2023, while the average circulating shares per person increased by 10.92% to 16,100 shares [2] - Major shareholders include Hong Kong Central Clearing Limited, holding 50.0449 million shares, an increase of 1.0271 million shares from the previous period [3] - The stock's trading activity on August 25, 2023, showed a net outflow of 35.78 million yuan in principal funds, with significant selling pressure [1]
蓝晓科技(300487):单季度利润创新高,提锂、生命科学、超纯水可期
Tianfeng Securities· 2025-08-22 08:16
Investment Rating - The investment rating for the company is "Buy" with a target price not specified [6] Core Views - The company achieved a record high profit in the second quarter, with a net profit margin showing significant improvement [2] - The revenue for the first half of 2025 was CNY 12.47 billion, a year-on-year decrease of 3.6%, while the net profit attributable to the parent company was CNY 4.45 billion, an increase of 10.0% [1][3] - The company is expected to see growth in its life sciences, ultra-pure water, and lithium extraction projects, with a forecasted net profit of CNY 10.11 billion, CNY 13.22 billion, and CNY 15.96 billion for 2025-2027 [4] Revenue and Profitability - In Q2 2025, the company reported revenue of CNY 6.71 billion, a year-on-year increase of 1.1% and a quarter-on-quarter increase of 16.3% [1] - The gross margin for Q2 was 51.66%, and the net margin was 37.75%, both showing upward trends [2] - Excluding the impact of the large lithium extraction project, revenue for the first half of 2025 grew by 4.26% [3] Business Segments - The revenue from adsorption materials was CNY 10.07 billion, a year-on-year increase of 3.40%, while system device revenue decreased by 36.53% [3] - The technical service revenue saw a significant increase of 217.55%, primarily due to increased project design income in the lithium extraction sector [3] - Key projects in life sciences and ultra-pure water have made significant progress, with plans for a new high-end materials industrial park in Shaanxi Province [4] Financial Forecasts - The company’s financial projections indicate a steady increase in revenue and net profit over the next few years, with expected revenues of CNY 3.07 billion in 2025 and CNY 5.36 billion in 2027 [5] - The projected net profit for 2025 is CNY 1.01 billion, with a growth rate of 28.48% [5] Market Position - The company operates in the basic chemicals and plastics industry, with a current market capitalization of approximately CNY 26.84 billion [7] - The stock has shown a price range between CNY 37.35 and CNY 68.02 over the past year [7]
蓝晓科技涨2.00%,成交额4663.33万元,主力资金净流出30.74万元
Xin Lang Zheng Quan· 2025-08-22 05:49
Core Viewpoint - Blue Sky Technology has shown a mixed performance in stock price and financial results, with a notable increase in net profit despite a slight decline in revenue [1][2]. Financial Performance - As of June 30, 2025, Blue Sky Technology reported a revenue of 1.247 billion yuan, a year-on-year decrease of 3.64% [2]. - The net profit attributable to shareholders was 445 million yuan, reflecting a year-on-year growth of 10.01% [2]. - Cumulative cash dividends since the A-share listing amount to 1.136 billion yuan, with 866 million yuan distributed over the past three years [3]. Stock Performance - On August 22, 2023, Blue Sky Technology's stock price increased by 2.00%, reaching 53.93 yuan per share, with a total market capitalization of 27.378 billion yuan [1]. - Year-to-date, the stock price has risen by 14.09%, with a 5-day increase of 5.54% and a 60-day increase of 18.89% [1]. Shareholder Structure - As of June 30, 2025, the number of shareholders decreased by 9.84% to 19,000, while the average circulating shares per person increased by 10.92% to 16,100 shares [2]. - The largest circulating shareholder is Hong Kong Central Clearing Limited, holding 50.0449 million shares, an increase of 1.0271 million shares from the previous period [3].
蓝晓科技(300487):2025中报点评:业绩稳健,建高端材料产业园加码生命科学
Yin He Zheng Quan· 2025-08-20 08:18
Investment Rating - The report maintains a "Recommended" rating for the company [1][5]. Core Insights - The company reported a revenue of 1.247 billion yuan for the first half of 2025, a year-on-year decrease of 3.64%, while the net profit attributable to shareholders increased by 10.01% to 445 million yuan [3]. - The gross profit margin and net profit margin improved significantly, reaching 51.26% and 35.97% respectively, with increases of 3.78 percentage points and 4.32 percentage points year-on-year, driven by higher contributions from high-margin businesses in life sciences, metal resources, and ultra-pure water [3]. - The company plans to invest 1.15 billion yuan in building a high-end materials industrial park in Pucheng to enhance its life sciences segment [3]. Financial Performance Summary - For the first half of 2025, the company achieved a net cash flow of 288 million yuan, reflecting a positive trend [3]. - The company’s asset-liability ratio stood at 36.30%, a decrease of 3.73 percentage points year-on-year, indicating low debt risk [3]. - The company’s revenue from adsorption materials was 1.007 billion yuan, a year-on-year increase of 3.40%, with significant growth in the water treatment, life sciences, and metal resources segments [3]. Future Projections - The company is projected to achieve net profits of 1.014 billion yuan, 1.209 billion yuan, and 1.527 billion yuan for the years 2025, 2026, and 2027 respectively, with corresponding P/E ratios of 26.98X, 22.63X, and 17.92X [5][4]. - Revenue is expected to grow at rates of 17.66%, 22.90%, and 17.27% for the years 2025, 2026, and 2027 respectively [4][7].